GLP-1 receptor agonists are a novel class of medications primarily used to manage type 2 diabetes. However, growing research suggests their potential applications extend beyond blood sugar control, impacting appetite regulation and promoting reduced body mass. When incorporated into a well-planned eating regimen, these agonists can significantly op